Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
Subcutaneous Rituximab for the Treatment of B-Cell Hematologic Malignancies: A Review of the Scientific Rationale and Clinical Development. [electronic resource] by
- Davies, Andrew
- Berge, Claude
- Boehnke, Axel
- Dadabhoy, Anjum
- Lugtenburg, Pieternella
- Rule, Simon
- Rummel, Mathias
- McIntyre, Christine
- Smith, Rodney
- Badoux, Xavier
Producer: 20180417
In:
Advances in therapy vol. 34
Availability: No items available.
|
|
|
5.
|
Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia. [electronic resource] by
- Assouline, Sarit
- Buccheri, Valeria
- Delmer, Alain
- Gaidano, Gianluca
- McIntyre, Christine
- Brewster, Michael
- Catalani, Olivier
- Hourcade-Potelleret, Florence
- Sayyed, Pakeeza
- Badoux, Xavier
Producer: 20160912
In:
British journal of clinical pharmacology vol. 80
Availability: No items available.
|
|
|
6.
|
Cross-talk between chronic lymphocytic leukemia cells and bone marrow endothelial cells: role of signal transducer and activator of transcription 3. [electronic resource] by
- Badoux, Xavier
- Bueso-Ramos, Carlos
- Harris, David
- Li, Ping
- Liu, Zhiming
- Burger, Jan
- O'Brien, Susan
- Ferrajoli, Alessandra
- Keating, Michael J
- Estrov, Zeev
Producer: 20120109
In:
Human pathology vol. 42
Availability: No items available.
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial. [electronic resource] by
- Assouline, Sarit
- Buccheri, Valeria
- Delmer, Alain
- Gaidano, Gianluca
- Trneny, Marek
- Berthillon, Natalia
- Brewster, Michael
- Catalani, Olivier
- Li, Sai
- McIntyre, Christine
- Sayyed, Pakeeza
- Badoux, Xavier
Producer: 20170710
In:
The Lancet. Haematology vol. 3
Availability: No items available.
|
|
|
10.
|
Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome. [electronic resource] by
- Tsimberidou, Apostolia M
- Wierda, William G
- Wen, Sijin
- Plunkett, William
- O'Brien, Susan
- Kipps, Thomas J
- Jones, Jeffrey A
- Badoux, Xavier
- Kantarjian, Hagop
- Keating, Michael J
Producer: 20140408
In:
Clinical lymphoma, myeloma & leukemia vol. 13
Availability: No items available.
|
|
|
11.
|
Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL. [electronic resource] by
- Badoux, Xavier C
- Keating, Michael J
- Wang, Xuemei
- O'Brien, Susan M
- Ferrajoli, Alessandra
- Faderl, Stefan
- Burger, Jan
- Koller, Charles
- Lerner, Susan
- Kantarjian, Hagop
- Wierda, William G
Producer: 20110511
In:
Blood vol. 117
Availability: No items available.
|
|
|
12.
|
Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia. [electronic resource] by
- Lee, Bang-Ning
- Gao, Hui
- Cohen, Evan N
- Badoux, Xavier
- Wierda, William G
- Estrov, Zeev
- Faderl, Stefan H
- Keating, Michael J
- Ferrajoli, Alessandra
- Reuben, James M
Producer: 20111013
In:
Cancer vol. 117
Availability: No items available.
|
|
|
13.
|
Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia. [electronic resource] by
- Badoux, Xavier C
- Keating, Michael J
- Wang, Xuemei
- O'Brien, Susan M
- Ferrajoli, Alessandra
- Faderl, Stefan
- Burger, Jan
- Koller, Charles
- Lerner, Susan
- Kantarjian, Hagop
- Wierda, William G
Producer: 20111024
In:
Blood vol. 118
Availability: No items available.
|
|
|
14.
|
Frontline chemoimmunotherapy with fludarabine, cyclophosphamide, alemtuzumab, and rituximab for high-risk chronic lymphocytic leukemia. [electronic resource] by
- Parikh, Sameer A
- Keating, Michael J
- O'Brien, Susan
- Wang, Xuemei
- Ferrajoli, Alessandra
- Faderl, Stefan
- Burger, Jan
- Koller, Charles
- Estrov, Zeev
- Badoux, Xavier
- Lerner, Susan
- Wierda, William G
Producer: 20111024
In:
Blood vol. 118
Availability: No items available.
|
|
|
15.
|
Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemia. [electronic resource] by
- Strati, Paolo
- Keating, Michael J
- Wierda, William G
- Badoux, Xavier C
- Calin, Steliana
- Reuben, James M
- O'Brien, Susan
- Kornblau, Steven M
- Kantarjian, Hagop M
- Gao, Hui
- Ferrajoli, Alessandra
Producer: 20131028
In:
Blood vol. 122
Availability: No items available.
|
|
|
16.
|
Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia. [electronic resource] by
- Badoux, Xavier C
- Keating, Michael J
- Wen, Sijin
- Lee, Bang-Ning
- Sivina, Mariela
- Reuben, James
- Wierda, William G
- O'Brien, Susan M
- Faderl, Stefan
- Kornblau, Steven M
- Burger, Jan A
- Ferrajoli, Alessandra
Producer: 20111202
In:
Blood vol. 118
Availability: No items available.
|
|
|
17.
|
Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial. [electronic resource] by
- Jones, Jeffrey A
- Robak, Tadeusz
- Brown, Jennifer R
- Awan, Farrukh T
- Badoux, Xavier
- Coutre, Steven
- Loscertales, Javier
- Taylor, Kerry
- Vandenberghe, Elisabeth
- Wach, Malgorzata
- Wagner-Johnston, Nina
- Ysebaert, Loic
- Dreiling, Lyndah
- Dubowy, Ronald
- Xing, Guan
- Flinn, Ian W
- Owen, Carolyn
Producer: 20180209
In:
The Lancet. Haematology vol. 4
Availability: No items available.
|